Front Page News

Clinical Research and Drug Development Session Highlights from 2023 SMA Research & Clinical Care Meeting

August 7, 2023
Posted in , ,

At the end of June, SMA researchers and clinicians from around the world met in Orlando, Florida, for the 2023 Annual SMA Research & Clinical […]

Read More ›

Genentech Releases SMA Community Letter

August 4, 2023
Posted in ,

Genentech recently issued an SMA community statement highlighting updates from the 2023 SMA Research & Clinical Care Meeting. These updates included: Investigating risdiplam treatment post […]

Read More ›

Thank You for an Amazing 2023 Annual SMA Conference!

July 24, 2023
Posted in , ,

Thank you to everyone who attended the 2023 Annual SMA Conference at Disney’s Yacht & Beach Club in Orlando, Florida! It was an impactful weekend […]

Read More ›

Big Week in Washington for Cure SMA-Supported Legislation

July 20, 2023
Posted in , ,

This week, bills to address everyday challenges faced by individuals with spinal muscular atrophy (SMA) took important steps forward in the U.S. Congress. A key […]

Read More ›

Cure SMA’s 2022 State of SMA Report

July 12, 2023
Posted in , ,

Cure SMA is pleased to announce the launch of the second annual State of SMA report. The purpose of this report is to share highlights […]

Read More ›

Individuals with SMA Describe New Travel Hiccups and Wheelchair Damage in Their Air Travels to Cure SMA National Conference

July 2, 2023
Posted in , ,

A record-number of individuals with spinal muscular atrophy (SMA), a neuromuscular disease, travelled to Orlando to attend Cure SMA’s national conference from June 29 to […]

Read More ›

Luke 18:1 Foundation Donates $500,000 to Cure SMA to Support Groundbreaking SMA Research and Care

June 30, 2023
Posted in , ,

Chicago, June 30, 2023 – Cure SMA receives a surprise gift in the amount of $500,181 from the Luke 18:1 Foundation, a 501(c)3 organization founded […]

Read More ›

Alcyone Therapeutics Receives FDA IDE Approval to Initiate Clinical Study of the ThecaFlex DRx™ System for Administration of SPINRAZA

June 28, 2023
Posted in ,

• Alcyone’s ThecaFlex DRx™ System is an implantable medical device in development to enable routine subcutaneous administration of therapeutics to the cerebrospinal fluid• First stage […]

Read More ›

Congressional Committee Approves Legislation to Improve Air Travel for People with SMA and other Disabilities

June 16, 2023
Posted in , ,

This week, a key committee in the U.S. House of Representatives unanimously approved (63-0) aviation legislation that will make air travel more accessible for individuals with SMA […]

Read More ›

Erin Trainor Memorial Fund will Match Donations for the funding of Care Centers

June 15, 2023
Posted in , ,

Double your donation to help double Cure SMA’s Care Center Network Care Centers guide our understanding of how SMA is changing, help us understand how […]

Read More ›
Scroll to Top